ACMD report on ketamine is here

First came the EU Drugs Agency report on Ketamine in Europe. Now the Advisory Council on the Misuse of Drugs recommended that ketamine should remain a class B controlled substance, calling for more support for healthcare professionals in tackling ketamine-related harms. Pulse added: Treat ketamine use as public health threat.